Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.

Le Treut, J; Sault, M C; Lena, H; Souquet, P J; Vergnenegre, A; Le Caer, H; Berard, H; Boffa, S; Monnet, I; Damotte, D; Chouaid, C

Le Treut, J; Sault, M C; Lena, H; Souquet, P J; Vergnenegre, A; Le Caer, H; Berard, H; Boffa, S; Monnet, I; Damotte, D; Chouaid, C.

Affiliation

Le Treut J; Department of Pneumology, Aix en Provence, France.

Ann Oncol ; 24(6): 1548-52, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23406729

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carcinoma, Large Cell/drug therapy; Carcinoma, Neuroendocrine/drug therapy; Lung Neoplasms/drug therapy; Adult; Aged; Carcinoma, Large Cell/mortality; Carcinoma, Large Cell/pathology; Carcinoma, Neuroendocrine/mortality; Carcinoma, Neuroendocrine/pathology; Cisplatin/administration & dosage; Disease-Free Survival; Etoposide/administration & dosage; Female; Follow-Up Studies; Humans; Lung Neoplasms/mortality; Lung Neoplasms/pathology; Male; Middle Aged; Prospective Studies

Key words

carcinoma; clinical trial phase II; large cell neuroendocrine tumours; small-cell lung cancer

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Neuroendocrine / Carcinoma, Large Cell / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google